Notice: Uninitialized string offset: 0 in C:\webapps\propertymentorgroup\wp-includes\class-wp-theme.php on line 1

Notice: Uninitialized string offset: 0 in C:\webapps\propertymentorgroup\wp-includes\class-wp-theme.php on line 1

Notice: Uninitialized string offset: 0 in C:\webapps\propertymentorgroup\wp-includes\rest-api\endpoints\class-wp-rest-taxonomies-controller.php on line 1

Notice: Uninitialized string offset: 0 in C:\webapps\propertymentorgroup\wp-includes\rest-api\endpoints\class-wp-rest-taxonomies-controller.php on line 1

Notice: Uninitialized string offset: 0 in C:\webapps\propertymentorgroup\wp-includes\rest-api\endpoints\class-wp-rest-application-passwords-controller.php on line 1

Notice: Uninitialized string offset: 0 in C:\webapps\propertymentorgroup\wp-includes\rest-api\endpoints\class-wp-rest-application-passwords-controller.php on line 1

Notice: Uninitialized string offset: 0 in C:\webapps\propertymentorgroup\wp-includes\block-patterns.php on line 1

Notice: Uninitialized string offset: 0 in C:\webapps\propertymentorgroup\wp-includes\block-patterns.php on line 1
Investor’s pick: NephroGenex (NASDAQ:NRX), U.S. Bancorp (NYSE:USB), Torchmark Corporation (NYSE:TMK), Rocky Brands (NASDAQ:RCKY), Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) - Property Mentor Group

Investor’s pick: NephroGenex (NASDAQ:NRX), U.S. Bancorp (NYSE:USB), Torchmark Corporation (NYSE:TMK), Rocky Brands (NASDAQ:RCKY), Ariad Pharmaceuticals Inc. (NASDAQ:ARIA)


NephroGenex Inc (Nasdaq:NRX) ripped higher Wednesday after the company reported cardiac safety study results for Pyridorin. Pyridorin showed no effect on the QT/QTc interval at the expected therapeutic dose of 300 mg and at a higher dose of 1200 mg. NephroGenex, Inc. (NASDAQ:NRX) in last trading activity moved up 187.10% to close at $13.35. Company weekly performance is 187.72% while its quarterly performance stands at 197.33%. NephroGenex, Inc. (NASDAQ:NRX) is 2.69% away from its 52 week high.

The company also recently announced a quarterly dividend, which is scheduled for Thursday, January 15th. Investors of record will be paid a dividend of $0.245 per share. This represents a $0.98 annualized dividend and a dividend yield of 2.18%. On last trading day U.S. Bancorp (NYSE:USB) decreased -1.34% to close at $44.95. Its volatility for the week is 1.05% while volatility for the month is 1.40%. USB’s sales growth for past 5 years was -0.20% and its EPS growth for past 5 years was 13.30%. U.S. Bancorp (NYSE:USB) monthly performance is 3.60%.

Torchmark Corporation (NYSE:TMK) cash dividend payment of $0.1267 per share is scheduled to be paid on January 30, 2015. Shareholders who purchased TMK stock prior to the ex-dividend date are eligible for the cash dividend payment. Torchmark Corporation (NYSE:TMK) has 1.10% insider ownership while its institutional ownership stands at 76.30%. In last trading activity company’s stock closed at $54.17.

Rocky Brands Inc (NASDAQ:RCKY) was upgraded by Zacks from an “underperform” rating to a “neutral” rating in a note issued to investors on Tuesday. The firm currently has a $14.50 price objective on the stock. Zacks‘s price objective would indicate a potential upside of 3.57% from the stock’s previous close. On Wednesday shares of Rocky Brands, Inc. (NASDAQ:RCKY) closed at $13.42. Company’s sales growth for last 5 years was -1.20% and EPS growth for next 5 years is recorded as 10.00%.

Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) announced that it has granted exclusive rights to privately-held pharmaceutical company Angelini Pharma to commercialize Iclusig in Central and Eastern Europe for the indications approved by the European Medicine Agency (EMA). Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) in last trading activity increased 0.81% to close at $6.87. Company weekly performance is 3.15% while its quarterly performance stands at 30.11%. Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) is -30.11% away from its 52 week high.


Leave a Reply

Your email address will not be published. Required fields are marked *